Arangassery Rosemary Bastian

Author

Also Known As

, A R Bastian, Arangassery R Bastian, Arangassery R. Bastian, Arangassery Rosemary Bastian, Arangassery Rosemary Bastian

Publications

921

Citations

H-Index

Concepts

All Affiliations

Janssen (Netherlands)Janssen (Belgium)Drexel University Janssen (United States)University of Oxford

About

Arangassery Rosemary Bastian is an author at Janssen (Netherlands) specializing in immunology, medicine, and virology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	176
2	Biomolecular Engineering	2	2	53
3	Natural Sciences	1	1	18
4	Allergy	1	1	13
5	Biochemistry	1	1	18

Arangassery Rosemary Bastian

Publications

862

Citations

H-Index

Page 1

	Year	Citations
Efficacy and Safety of an Ad26.RSV.preF–RSV preF Protein Vaccine in Older Adults Ann R. Falsey, Kristi L. Williams, Efi Gymnopoulou, New England Journal of Medicine	2023	138
Phase 1 Safety and Immunogenicity Study of a Respiratory Syncytial Virus Vaccine With an Adenovirus 26 Vector Encoding Prefusion F (Ad26.RSV.preF) in Adults Aged ≥60 Years Kristi L. Williams, Arangassery Rosemary Bastian, Robert Feldman, The Journal of Infectious Diseases	2020	109
Prevention of Respiratory Syncytial Virus Infection in Healthy Adults by a Single Immunization of Ad26.RSV.preF in a Human Challenge Study Jerald Sadoff, Els De Paepe, John P. DeVincenzo, The Journal of Infectious Diseases	2021	90
Solid‐State Nanopore Detection of Protein Complexes: Applications in Healthcare and Protein Kinetics Kevin J. Freedman, Arangassery Rosemary Bastian, Irwin Chaiken, Small	2012	70
Mechanism of Multivalent Nanoparticle Encounter with HIV-1 for Potency Enhancement of Peptide Triazole Virus Inactivation Arangassery Rosemary Bastian, Aakansha Nangarlia, Lauren D. Bailey, Journal of Biological Chemistry	2014	57
Safety and Immunogenicity of the Ad26.RSV.preF Investigational Vaccine Coadministered With an Influenza Vaccine in Older Adults Jerald Sadoff, Els De Paepe, Wouter Haazen, The Journal of Infectious Diseases	2020	57
Antibody effector functions are associated with protection from respiratory syncytial virus Yannic C. Bartsch, Deniz Cizmeci, Jaewon Kang, Cell VaccinationRespiratory Virus ImmunityAntibody Effector FunctionsMedicineImmunology	2022	56
Cell‐Free HIV‐1 Virucidal Action by Modified Peptide Triazole Inhibitors of Env gp120 Arangassery Rosemary Bastian, Kantharaju, Karyn McFadden, ChemMedChem Env Gp120Hiv-1 Gp120Host CellsMedicineHuman Retrovirus	2011	42
Interactions of peptide triazole thiols with Env gp120 induce irreversible breakdown and inactivation of HIV-1 virions Arangassery Rosemary Bastian, Mark Contarino, Lauren D. Bailey, Retrovirology	2013	42
Phase 1/2a Safety and Immunogenicity of an Adenovirus 26 Vector Respiratory Syncytial Virus (RSV) Vaccine Encoding Prefusion F in Adults 18–50 Years and RSV-Seropositive Children 12–24 Months Arabella Stuart, Miia Virta, Kristi L. Williams, The Journal of Infectious Diseases	2022	37

Page 1